A discussion among financial industry leaders and academics about the current state of the markets and what we can expect in the coming months and years.
After more than a decade in pharmaceutical business development, Bill Desmarais, EMBA '16, found himself caught between two identities—too scientific for the business side and too business-oriented for the scientists. Seeking the skills and credibility to bridge that gap, he enrolled in the MIT Exec...
Adela Jamal, SFMBA ’22, and Sebastian Barriga, SFMBA ’22, talk about their journey from diverse global careers to launching an applied AI-focused venture fund.
Use this framework to limit operational damage and monetary losses.
When stakeholders become more involved in generative AI design and implementation, it’s more likely that such tools will augment work rather than displace workers.
Shawna Young, EMBA ’15, joins Christopher Reichert, MOT ’04, on the latest episode of "Sloanies Talking with Sloanies."
Change is afoot in venture capital, from machine learning to the impacts of COVID-19. Here’s a quick primer on what’s happening now.
Robert Merton (School of Management Distinguished Professor of Finance at MIT Sloan School of Management, 1997 Nobel Prize in Economics and GCFP co-director) has long advocated for better ways to save for retirement. His concept of Retirement Security Bonds (RSB’s) would allow [...]
Platform companies are hiring. Here’s what they should be looking for.
